nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—SLC22A2—Estradiol—osteoporosis	0.12	0.249	CbGbCtD
Memantine—CYP2B6—Raloxifene—osteoporosis	0.1	0.207	CbGbCtD
Memantine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0968	0.2	CbGbCtD
Memantine—CYP2B6—Cholecalciferol—osteoporosis	0.0774	0.16	CbGbCtD
Memantine—CYP2C19—Cholecalciferol—osteoporosis	0.0492	0.102	CbGbCtD
Memantine—CYP2C19—Estradiol—osteoporosis	0.0396	0.082	CbGbCtD
Memantine—Cough—Conjugated Estrogens—osteoporosis	0.000184	0.00038	CcSEcCtD
Memantine—Dyspnoea—Risedronate—osteoporosis	0.000183	0.000378	CcSEcCtD
Memantine—Erythema multiforme—Estradiol—osteoporosis	0.000183	0.000378	CcSEcCtD
Memantine—Hypotension—Pamidronate—osteoporosis	0.000183	0.000377	CcSEcCtD
Memantine—Convulsion—Conjugated Estrogens—osteoporosis	0.000182	0.000377	CcSEcCtD
Memantine—Dry mouth—Zoledronate—osteoporosis	0.000182	0.000376	CcSEcCtD
Memantine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000182	0.000376	CcSEcCtD
Memantine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000182	0.000375	CcSEcCtD
Memantine—Pruritus—Alendronate—osteoporosis	0.000181	0.000374	CcSEcCtD
Memantine—Dyspepsia—Risedronate—osteoporosis	0.000181	0.000374	CcSEcCtD
Memantine—Eye disorder—Estradiol—osteoporosis	0.000181	0.000374	CcSEcCtD
Memantine—Tinnitus—Estradiol—osteoporosis	0.00018	0.000373	CcSEcCtD
Memantine—Constipation—Ethinyl Estradiol—osteoporosis	0.00018	0.000372	CcSEcCtD
Memantine—Confusional state—Zoledronate—osteoporosis	0.00018	0.000372	CcSEcCtD
Memantine—Hypersensitivity—Calcitriol—osteoporosis	0.00018	0.000372	CcSEcCtD
Memantine—Flushing—Estradiol—osteoporosis	0.00018	0.000371	CcSEcCtD
Memantine—Cardiac disorder—Estradiol—osteoporosis	0.00018	0.000371	CcSEcCtD
Memantine—Chest pain—Conjugated Estrogens—osteoporosis	0.000179	0.00037	CcSEcCtD
Memantine—Myalgia—Conjugated Estrogens—osteoporosis	0.000179	0.00037	CcSEcCtD
Memantine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000179	0.00037	CcSEcCtD
Memantine—Asthenia—Ibandronate—osteoporosis	0.000179	0.00037	CcSEcCtD
Memantine—Anxiety—Conjugated Estrogens—osteoporosis	0.000179	0.000369	CcSEcCtD
Memantine—Nausea—Etidronic acid—osteoporosis	0.000179	0.000369	CcSEcCtD
Memantine—Oedema—Zoledronate—osteoporosis	0.000178	0.000369	CcSEcCtD
Memantine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000178	0.000368	CcSEcCtD
Memantine—Diarrhoea—Estropipate—osteoporosis	0.000178	0.000368	CcSEcCtD
Memantine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000177	0.000367	CcSEcCtD
Memantine—Infection—Zoledronate—osteoporosis	0.000177	0.000366	CcSEcCtD
Memantine—Fatigue—Risedronate—osteoporosis	0.000177	0.000366	CcSEcCtD
Memantine—Insomnia—Pamidronate—osteoporosis	0.000177	0.000365	CcSEcCtD
Memantine—Pruritus—Ibandronate—osteoporosis	0.000176	0.000364	CcSEcCtD
Memantine—Constipation—Risedronate—osteoporosis	0.000176	0.000363	CcSEcCtD
Memantine—Pain—Risedronate—osteoporosis	0.000176	0.000363	CcSEcCtD
Memantine—Angiopathy—Estradiol—osteoporosis	0.000176	0.000363	CcSEcCtD
Memantine—Shock—Zoledronate—osteoporosis	0.000176	0.000363	CcSEcCtD
Memantine—Paraesthesia—Pamidronate—osteoporosis	0.000175	0.000362	CcSEcCtD
Memantine—Diarrhoea—Alendronate—osteoporosis	0.000175	0.000362	CcSEcCtD
Memantine—Asthenia—Calcitriol—osteoporosis	0.000175	0.000362	CcSEcCtD
Memantine—Nervous system disorder—Zoledronate—osteoporosis	0.000175	0.000361	CcSEcCtD
Memantine—Immune system disorder—Estradiol—osteoporosis	0.000175	0.000361	CcSEcCtD
Memantine—Thrombocytopenia—Zoledronate—osteoporosis	0.000175	0.000361	CcSEcCtD
Memantine—Mediastinal disorder—Estradiol—osteoporosis	0.000174	0.00036	CcSEcCtD
Memantine—Dyspnoea—Pamidronate—osteoporosis	0.000174	0.00036	CcSEcCtD
Memantine—Tachycardia—Zoledronate—osteoporosis	0.000174	0.00036	CcSEcCtD
Memantine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000174	0.000359	CcSEcCtD
Memantine—Chills—Estradiol—osteoporosis	0.000174	0.000359	CcSEcCtD
Memantine—Somnolence—Pamidronate—osteoporosis	0.000174	0.000359	CcSEcCtD
Memantine—Skin disorder—Zoledronate—osteoporosis	0.000173	0.000358	CcSEcCtD
Memantine—Pruritus—Calcitriol—osteoporosis	0.000173	0.000357	CcSEcCtD
Memantine—Hyperhidrosis—Zoledronate—osteoporosis	0.000173	0.000356	CcSEcCtD
Memantine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000172	0.000356	CcSEcCtD
Memantine—Diarrhoea—Raloxifene—osteoporosis	0.000172	0.000356	CcSEcCtD
Memantine—Dyspepsia—Pamidronate—osteoporosis	0.000172	0.000355	CcSEcCtD
Memantine—Dizziness—Estropipate—osteoporosis	0.000172	0.000355	CcSEcCtD
Memantine—Oedema—Conjugated Estrogens—osteoporosis	0.000172	0.000355	CcSEcCtD
Memantine—Alopecia—Estradiol—osteoporosis	0.000171	0.000353	CcSEcCtD
Memantine—Infection—Conjugated Estrogens—osteoporosis	0.000171	0.000353	CcSEcCtD
Memantine—Diarrhoea—Ibandronate—osteoporosis	0.000171	0.000352	CcSEcCtD
Memantine—Anorexia—Zoledronate—osteoporosis	0.00017	0.000351	CcSEcCtD
Memantine—Decreased appetite—Pamidronate—osteoporosis	0.00017	0.000351	CcSEcCtD
Memantine—Mental disorder—Estradiol—osteoporosis	0.00017	0.00035	CcSEcCtD
Memantine—Dizziness—Alendronate—osteoporosis	0.000169	0.00035	CcSEcCtD
Memantine—Shock—Conjugated Estrogens—osteoporosis	0.000169	0.000349	CcSEcCtD
Memantine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000169	0.000348	CcSEcCtD
Memantine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000169	0.000348	CcSEcCtD
Memantine—Malnutrition—Estradiol—osteoporosis	0.000168	0.000348	CcSEcCtD
Memantine—Fatigue—Pamidronate—osteoporosis	0.000168	0.000348	CcSEcCtD
Memantine—Gastrointestinal pain—Risedronate—osteoporosis	0.000168	0.000347	CcSEcCtD
Memantine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000168	0.000346	CcSEcCtD
Memantine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000167	0.000346	CcSEcCtD
Memantine—Constipation—Pamidronate—osteoporosis	0.000167	0.000345	CcSEcCtD
Memantine—Pain—Pamidronate—osteoporosis	0.000167	0.000345	CcSEcCtD
Memantine—Diarrhoea—Calcitriol—osteoporosis	0.000167	0.000345	CcSEcCtD
Memantine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000167	0.000345	CcSEcCtD
Memantine—Hypotension—Zoledronate—osteoporosis	0.000167	0.000344	CcSEcCtD
Memantine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000167	0.000344	CcSEcCtD
Memantine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000167	0.000344	CcSEcCtD
Memantine—Dizziness—Raloxifene—osteoporosis	0.000167	0.000344	CcSEcCtD
Memantine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000166	0.000343	CcSEcCtD
Memantine—Flatulence—Estradiol—osteoporosis	0.000166	0.000343	CcSEcCtD
Memantine—Tension—Estradiol—osteoporosis	0.000165	0.000342	CcSEcCtD
Memantine—Vomiting—Estropipate—osteoporosis	0.000165	0.000342	CcSEcCtD
Memantine—Dysgeusia—Estradiol—osteoporosis	0.000165	0.000341	CcSEcCtD
Memantine—Dizziness—Ibandronate—osteoporosis	0.000165	0.000341	CcSEcCtD
Memantine—Rash—Estropipate—osteoporosis	0.000164	0.000339	CcSEcCtD
Memantine—Dermatitis—Estropipate—osteoporosis	0.000164	0.000338	CcSEcCtD
Memantine—Anorexia—Conjugated Estrogens—osteoporosis	0.000164	0.000338	CcSEcCtD
Memantine—Nervousness—Estradiol—osteoporosis	0.000164	0.000338	CcSEcCtD
Memantine—Urticaria—Risedronate—osteoporosis	0.000163	0.000337	CcSEcCtD
Memantine—Back pain—Estradiol—osteoporosis	0.000163	0.000337	CcSEcCtD
Memantine—Headache—Estropipate—osteoporosis	0.000163	0.000337	CcSEcCtD
Memantine—Vomiting—Alendronate—osteoporosis	0.000163	0.000336	CcSEcCtD
Memantine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000163	0.000336	CcSEcCtD
Memantine—Abdominal pain—Risedronate—osteoporosis	0.000162	0.000336	CcSEcCtD
Memantine—Body temperature increased—Risedronate—osteoporosis	0.000162	0.000336	CcSEcCtD
Memantine—Rash—Alendronate—osteoporosis	0.000161	0.000334	CcSEcCtD
Memantine—Insomnia—Zoledronate—osteoporosis	0.000161	0.000333	CcSEcCtD
Memantine—Dermatitis—Alendronate—osteoporosis	0.000161	0.000333	CcSEcCtD
Memantine—Feeling abnormal—Pamidronate—osteoporosis	0.000161	0.000333	CcSEcCtD
Memantine—Hypotension—Conjugated Estrogens—osteoporosis	0.000161	0.000332	CcSEcCtD
Memantine—Headache—Alendronate—osteoporosis	0.00016	0.000331	CcSEcCtD
Memantine—GRIN1—Developmental Biology—TLN1—osteoporosis	0.00016	0.00489	CbGpPWpGaD
Memantine—Paraesthesia—Zoledronate—osteoporosis	0.00016	0.000331	CcSEcCtD
Memantine—Vomiting—Raloxifene—osteoporosis	0.00016	0.000331	CcSEcCtD
Memantine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00016	0.00033	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—IRS2—osteoporosis	0.00016	0.00487	CbGpPWpGaD
Memantine—Dyspnoea—Zoledronate—osteoporosis	0.000159	0.000329	CcSEcCtD
Memantine—Rash—Raloxifene—osteoporosis	0.000159	0.000328	CcSEcCtD
Memantine—Dermatitis—Raloxifene—osteoporosis	0.000159	0.000328	CcSEcCtD
Memantine—Somnolence—Zoledronate—osteoporosis	0.000159	0.000328	CcSEcCtD
Memantine—Vomiting—Ibandronate—osteoporosis	0.000159	0.000328	CcSEcCtD
Memantine—GRIN1—Developmental Biology—ACTG1—osteoporosis	0.000158	0.00483	CbGpPWpGaD
Memantine—Tremor—Estradiol—osteoporosis	0.000158	0.000326	CcSEcCtD
Memantine—Headache—Raloxifene—osteoporosis	0.000158	0.000326	CcSEcCtD
Memantine—Rash—Ibandronate—osteoporosis	0.000157	0.000325	CcSEcCtD
Memantine—Dermatitis—Ibandronate—osteoporosis	0.000157	0.000324	CcSEcCtD
Memantine—Dyspepsia—Zoledronate—osteoporosis	0.000157	0.000324	CcSEcCtD
Memantine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000157	0.000323	CcSEcCtD
Memantine—Ill-defined disorder—Estradiol—osteoporosis	0.000156	0.000323	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—TLN1—osteoporosis	0.000156	0.00477	CbGpPWpGaD
Memantine—Headache—Ibandronate—osteoporosis	0.000156	0.000323	CcSEcCtD
Memantine—Insomnia—Conjugated Estrogens—osteoporosis	0.000155	0.000321	CcSEcCtD
Memantine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000155	0.000321	CcSEcCtD
Memantine—Vomiting—Calcitriol—osteoporosis	0.000155	0.000321	CcSEcCtD
Memantine—Decreased appetite—Zoledronate—osteoporosis	0.000155	0.00032	CcSEcCtD
Memantine—Agitation—Estradiol—osteoporosis	0.000155	0.00032	CcSEcCtD
Memantine—Nausea—Estropipate—osteoporosis	0.000154	0.000319	CcSEcCtD
Memantine—Abdominal pain—Pamidronate—osteoporosis	0.000154	0.000319	CcSEcCtD
Memantine—Body temperature increased—Pamidronate—osteoporosis	0.000154	0.000319	CcSEcCtD
Memantine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000154	0.000319	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—ACTG1—osteoporosis	0.000154	0.00471	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000154	0.000318	CcSEcCtD
Memantine—Rash—Calcitriol—osteoporosis	0.000154	0.000318	CcSEcCtD
Memantine—Fatigue—Zoledronate—osteoporosis	0.000154	0.000318	CcSEcCtD
Memantine—Dermatitis—Calcitriol—osteoporosis	0.000154	0.000318	CcSEcCtD
Memantine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000153	0.000316	CcSEcCtD
Memantine—Headache—Calcitriol—osteoporosis	0.000153	0.000316	CcSEcCtD
Memantine—Somnolence—Conjugated Estrogens—osteoporosis	0.000153	0.000316	CcSEcCtD
Memantine—Constipation—Zoledronate—osteoporosis	0.000153	0.000315	CcSEcCtD
Memantine—Pain—Zoledronate—osteoporosis	0.000153	0.000315	CcSEcCtD
Memantine—Nausea—Alendronate—osteoporosis	0.000152	0.000314	CcSEcCtD
Memantine—Malaise—Estradiol—osteoporosis	0.000152	0.000314	CcSEcCtD
Memantine—Hypersensitivity—Risedronate—osteoporosis	0.000151	0.000313	CcSEcCtD
Memantine—Vertigo—Estradiol—osteoporosis	0.000151	0.000313	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000151	0.00462	CbGpPWpGaD
Memantine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000151	0.000312	CcSEcCtD
Memantine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000151	0.000312	CcSEcCtD
Memantine—Syncope—Estradiol—osteoporosis	0.000151	0.000312	CcSEcCtD
Memantine—Nausea—Raloxifene—osteoporosis	0.00015	0.000309	CcSEcCtD
Memantine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000149	0.000309	CcSEcCtD
Memantine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000149	0.000308	CcSEcCtD
Memantine—Palpitations—Estradiol—osteoporosis	0.000149	0.000308	CcSEcCtD
Memantine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000148	0.000306	CcSEcCtD
Memantine—Fatigue—Conjugated Estrogens—osteoporosis	0.000148	0.000306	CcSEcCtD
Memantine—Nausea—Ibandronate—osteoporosis	0.000148	0.000306	CcSEcCtD
Memantine—Loss of consciousness—Estradiol—osteoporosis	0.000148	0.000306	CcSEcCtD
Memantine—Asthenia—Risedronate—osteoporosis	0.000147	0.000305	CcSEcCtD
Memantine—Feeling abnormal—Zoledronate—osteoporosis	0.000147	0.000304	CcSEcCtD
Memantine—Cough—Estradiol—osteoporosis	0.000147	0.000304	CcSEcCtD
Memantine—Constipation—Conjugated Estrogens—osteoporosis	0.000147	0.000304	CcSEcCtD
Memantine—Pain—Conjugated Estrogens—osteoporosis	0.000147	0.000304	CcSEcCtD
Memantine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000146	0.000301	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—CYP27A1—osteoporosis	0.000146	0.00444	CbGpPWpGaD
Memantine—Hypertension—Estradiol—osteoporosis	0.000145	0.000301	CcSEcCtD
Memantine—Pruritus—Risedronate—osteoporosis	0.000145	0.0003	CcSEcCtD
Memantine—Nausea—Calcitriol—osteoporosis	0.000145	0.0003	CcSEcCtD
Memantine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000144	0.000298	CcSEcCtD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000144	0.0044	CbGpPWpGaD
Memantine—Hypersensitivity—Pamidronate—osteoporosis	0.000144	0.000297	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000144	0.00439	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000144	0.00438	CbGpPWpGaD
Memantine—Myalgia—Estradiol—osteoporosis	0.000143	0.000296	CcSEcCtD
Memantine—Chest pain—Estradiol—osteoporosis	0.000143	0.000296	CcSEcCtD
Memantine—Arthralgia—Estradiol—osteoporosis	0.000143	0.000296	CcSEcCtD
Memantine—Anxiety—Estradiol—osteoporosis	0.000143	0.000295	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—IRS1—osteoporosis	0.000143	0.00436	CbGpPWpGaD
Memantine—Urticaria—Zoledronate—osteoporosis	0.000142	0.000293	CcSEcCtD
Memantine—Discomfort—Estradiol—osteoporosis	0.000142	0.000293	CcSEcCtD
Memantine—Body temperature increased—Zoledronate—osteoporosis	0.000141	0.000291	CcSEcCtD
Memantine—Abdominal pain—Zoledronate—osteoporosis	0.000141	0.000291	CcSEcCtD
Memantine—Diarrhoea—Risedronate—osteoporosis	0.000141	0.00029	CcSEcCtD
Memantine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000141	0.00029	CcSEcCtD
Memantine—Dry mouth—Estradiol—osteoporosis	0.00014	0.00029	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.00014	0.00428	CbGpPWpGaD
Memantine—Asthenia—Pamidronate—osteoporosis	0.00014	0.00029	CcSEcCtD
Memantine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000139	0.000288	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—IRS1—osteoporosis	0.000139	0.00425	CbGpPWpGaD
Memantine—Confusional state—Estradiol—osteoporosis	0.000139	0.000286	CcSEcCtD
Memantine—Pruritus—Pamidronate—osteoporosis	0.000138	0.000286	CcSEcCtD
Memantine—Oedema—Estradiol—osteoporosis	0.000138	0.000284	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—TNF—osteoporosis	0.000137	0.00419	CbGpPWpGaD
Memantine—Infection—Estradiol—osteoporosis	0.000137	0.000282	CcSEcCtD
Memantine—Urticaria—Conjugated Estrogens—osteoporosis	0.000136	0.000282	CcSEcCtD
Memantine—Dizziness—Risedronate—osteoporosis	0.000136	0.000281	CcSEcCtD
Memantine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000136	0.000281	CcSEcCtD
Memantine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000136	0.000281	CcSEcCtD
Memantine—Shock—Estradiol—osteoporosis	0.000135	0.000279	CcSEcCtD
Memantine—Nervous system disorder—Estradiol—osteoporosis	0.000135	0.000279	CcSEcCtD
Memantine—Tachycardia—Estradiol—osteoporosis	0.000134	0.000277	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000134	0.0041	CbGpPWpGaD
Memantine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000134	0.000277	CcSEcCtD
Memantine—Diarrhoea—Pamidronate—osteoporosis	0.000134	0.000276	CcSEcCtD
Memantine—Skin disorder—Estradiol—osteoporosis	0.000134	0.000276	CcSEcCtD
Memantine—Hyperhidrosis—Estradiol—osteoporosis	0.000133	0.000275	CcSEcCtD
Memantine—Rash—Ethinyl Estradiol—osteoporosis	0.000133	0.000275	CcSEcCtD
Memantine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000133	0.000274	CcSEcCtD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000132	0.00404	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000132	0.00404	CbGpPWpGaD
Memantine—Headache—Ethinyl Estradiol—osteoporosis	0.000132	0.000273	CcSEcCtD
Memantine—Hypersensitivity—Zoledronate—osteoporosis	0.000131	0.000272	CcSEcCtD
Memantine—Vomiting—Risedronate—osteoporosis	0.000131	0.00027	CcSEcCtD
Memantine—Rash—Risedronate—osteoporosis	0.00013	0.000268	CcSEcCtD
Memantine—Dermatitis—Risedronate—osteoporosis	0.000129	0.000267	CcSEcCtD
Memantine—Dizziness—Pamidronate—osteoporosis	0.000129	0.000267	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—PTH1R—osteoporosis	0.000129	0.00393	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CALCR—osteoporosis	0.000129	0.00393	CbGpPWpGaD
Memantine—Headache—Risedronate—osteoporosis	0.000129	0.000266	CcSEcCtD
Memantine—Asthenia—Zoledronate—osteoporosis	0.000128	0.000264	CcSEcCtD
Memantine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000127	0.000262	CcSEcCtD
Memantine—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	0.000126	0.00386	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—ADCY5—osteoporosis	0.000126	0.00386	CbGpPWpGaD
Memantine—Pruritus—Zoledronate—osteoporosis	0.000126	0.000261	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000126	0.00384	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000125	0.000259	CcSEcCtD
Memantine—Nausea—Ethinyl Estradiol—osteoporosis	0.000125	0.000259	CcSEcCtD
Memantine—Insomnia—Estradiol—osteoporosis	0.000124	0.000257	CcSEcCtD
Memantine—Vomiting—Pamidronate—osteoporosis	0.000124	0.000257	CcSEcCtD
Memantine—Paraesthesia—Estradiol—osteoporosis	0.000123	0.000255	CcSEcCtD
Memantine—Asthenia—Conjugated Estrogens—osteoporosis	0.000123	0.000255	CcSEcCtD
Memantine—GRIN1—Developmental Biology—WNT1—osteoporosis	0.000123	0.00376	CbGpPWpGaD
Memantine—Rash—Pamidronate—osteoporosis	0.000123	0.000254	CcSEcCtD
Memantine—Dermatitis—Pamidronate—osteoporosis	0.000123	0.000254	CcSEcCtD
Memantine—Dyspnoea—Estradiol—osteoporosis	0.000123	0.000253	CcSEcCtD
Memantine—Headache—Pamidronate—osteoporosis	0.000122	0.000253	CcSEcCtD
Memantine—Somnolence—Estradiol—osteoporosis	0.000122	0.000253	CcSEcCtD
Memantine—Diarrhoea—Zoledronate—osteoporosis	0.000122	0.000252	CcSEcCtD
Memantine—Nausea—Risedronate—osteoporosis	0.000122	0.000252	CcSEcCtD
Memantine—Pruritus—Conjugated Estrogens—osteoporosis	0.000122	0.000251	CcSEcCtD
Memantine—Dyspepsia—Estradiol—osteoporosis	0.000121	0.00025	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—WNT1—osteoporosis	0.00012	0.00367	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TNF—osteoporosis	0.00012	0.00366	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL1B—osteoporosis	0.00012	0.00366	CbGpPWpGaD
Memantine—Decreased appetite—Estradiol—osteoporosis	0.00012	0.000247	CcSEcCtD
Memantine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000119	0.000245	CcSEcCtD
Memantine—Fatigue—Estradiol—osteoporosis	0.000119	0.000245	CcSEcCtD
Memantine—Dizziness—Zoledronate—osteoporosis	0.000118	0.000244	CcSEcCtD
Memantine—Pain—Estradiol—osteoporosis	0.000118	0.000243	CcSEcCtD
Memantine—Constipation—Estradiol—osteoporosis	0.000118	0.000243	CcSEcCtD
Memantine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000118	0.000243	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—TNF—osteoporosis	0.000117	0.00356	CbGpPWpGaD
Memantine—Nausea—Pamidronate—osteoporosis	0.000116	0.00024	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000115	0.00351	CbGpPWpGaD
Memantine—Dizziness—Conjugated Estrogens—osteoporosis	0.000114	0.000235	CcSEcCtD
Memantine—Vomiting—Zoledronate—osteoporosis	0.000113	0.000234	CcSEcCtD
Memantine—Feeling abnormal—Estradiol—osteoporosis	0.000113	0.000234	CcSEcCtD
Memantine—Rash—Zoledronate—osteoporosis	0.000113	0.000232	CcSEcCtD
Memantine—Gastrointestinal pain—Estradiol—osteoporosis	0.000112	0.000232	CcSEcCtD
Memantine—Dermatitis—Zoledronate—osteoporosis	0.000112	0.000232	CcSEcCtD
Memantine—Headache—Zoledronate—osteoporosis	0.000112	0.000231	CcSEcCtD
Memantine—GRIN1—Neuronal System—ADCY5—osteoporosis	0.00011	0.00336	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	0.00011	0.00336	CbGpPWpGaD
Memantine—Vomiting—Conjugated Estrogens—osteoporosis	0.000109	0.000226	CcSEcCtD
Memantine—Urticaria—Estradiol—osteoporosis	0.000109	0.000226	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CNR2—osteoporosis	0.000109	0.00333	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000109	0.00332	CbGpPWpGaD
Memantine—Abdominal pain—Estradiol—osteoporosis	0.000109	0.000225	CcSEcCtD
Memantine—Body temperature increased—Estradiol—osteoporosis	0.000109	0.000225	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	0.000109	0.00331	CbGpPWpGaD
Memantine—Rash—Conjugated Estrogens—osteoporosis	0.000108	0.000224	CcSEcCtD
Memantine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000108	0.000224	CcSEcCtD
Memantine—Headache—Conjugated Estrogens—osteoporosis	0.000108	0.000222	CcSEcCtD
Memantine—GRIN2B—Neuronal System—ADCY5—osteoporosis	0.000107	0.00328	CbGpPWpGaD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000107	0.00327	CbGpPWpGaD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000107	0.00326	CbGpPWpGaD
Memantine—Nausea—Zoledronate—osteoporosis	0.000106	0.000219	CcSEcCtD
Memantine—Nausea—Conjugated Estrogens—osteoporosis	0.000102	0.000211	CcSEcCtD
Memantine—Hypersensitivity—Estradiol—osteoporosis	0.000101	0.000209	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000101	0.00309	CbGpPWpGaD
Memantine—Asthenia—Estradiol—osteoporosis	9.87e-05	0.000204	CcSEcCtD
Memantine—Pruritus—Estradiol—osteoporosis	9.73e-05	0.000201	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL1B—osteoporosis	9.58e-05	0.00292	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	9.48e-05	0.00289	CbGpPWpGaD
Memantine—Diarrhoea—Estradiol—osteoporosis	9.41e-05	0.000194	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—MYC—osteoporosis	9.33e-05	0.00285	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TGFB1—osteoporosis	9.31e-05	0.00284	CbGpPWpGaD
Memantine—Dizziness—Estradiol—osteoporosis	9.09e-05	0.000188	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—AGER—osteoporosis	8.86e-05	0.0027	CbGpPWpGaD
Memantine—Vomiting—Estradiol—osteoporosis	8.74e-05	0.000181	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TNF—osteoporosis	8.69e-05	0.00265	CbGpPWpGaD
Memantine—Rash—Estradiol—osteoporosis	8.67e-05	0.000179	CcSEcCtD
Memantine—Dermatitis—Estradiol—osteoporosis	8.66e-05	0.000179	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	8.66e-05	0.00264	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.65e-05	0.00264	CbGpPWpGaD
Memantine—Headache—Estradiol—osteoporosis	8.61e-05	0.000178	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—TNF—osteoporosis	8.35e-05	0.00255	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.21e-05	0.00251	CbGpPWpGaD
Memantine—Nausea—Estradiol—osteoporosis	8.17e-05	0.000169	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.07e-05	0.00246	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	7.65e-05	0.00233	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	7.54e-05	0.0023	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—ADCY5—osteoporosis	7.48e-05	0.00228	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.36e-05	0.00225	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PTH1R—osteoporosis	7.28e-05	0.00222	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CALCR—osteoporosis	7.28e-05	0.00222	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.12e-05	0.00217	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6R—osteoporosis	7.02e-05	0.00214	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL6—osteoporosis	7.01e-05	0.00214	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.97e-05	0.00213	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—TNF—osteoporosis	6.95e-05	0.00212	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6R—osteoporosis	6.84e-05	0.00209	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTH—osteoporosis	6.77e-05	0.00207	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL6—osteoporosis	6.74e-05	0.00206	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CALCR—osteoporosis	6.61e-05	0.00202	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTH1R—osteoporosis	6.61e-05	0.00202	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CNR2—osteoporosis	6.6e-05	0.00201	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.54e-05	0.002	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—WNT1—osteoporosis	6.2e-05	0.00189	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—LEP—osteoporosis	5.97e-05	0.00182	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—FDPS—osteoporosis	5.85e-05	0.00179	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PKM—osteoporosis	5.85e-05	0.00179	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—LEP—osteoporosis	5.82e-05	0.00178	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—ADCY5—osteoporosis	5.8e-05	0.00177	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—MGLL—osteoporosis	5.78e-05	0.00177	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	5.78e-05	0.00176	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—ADCY5—osteoporosis	5.73e-05	0.00175	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	5.7e-05	0.00174	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—POMC—osteoporosis	5.7e-05	0.00174	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—LEP—osteoporosis	5.63e-05	0.00172	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL6—osteoporosis	5.61e-05	0.00171	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTHLH—osteoporosis	5.61e-05	0.00171	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PGLS—osteoporosis	5.55e-05	0.00169	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPD2—osteoporosis	5.55e-05	0.00169	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.42e-05	0.00166	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PKM—osteoporosis	5.37e-05	0.00164	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—FDPS—osteoporosis	5.37e-05	0.00164	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.28e-05	0.00161	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MGLL—osteoporosis	5.25e-05	0.0016	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPD2—osteoporosis	5.09e-05	0.00155	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PGLS—osteoporosis	5.09e-05	0.00155	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ATIC—osteoporosis	5.07e-05	0.00155	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PNP—osteoporosis	5.07e-05	0.00155	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6R—osteoporosis	5.01e-05	0.00153	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CALCA—osteoporosis	4.94e-05	0.00151	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6R—osteoporosis	4.88e-05	0.00149	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ATIC—osteoporosis	4.66e-05	0.00142	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PNP—osteoporosis	4.66e-05	0.00142	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—POMC—osteoporosis	4.6e-05	0.0014	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PKM—osteoporosis	4.34e-05	0.00132	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—FDPS—osteoporosis	4.34e-05	0.00132	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SOST—osteoporosis	4.32e-05	0.00132	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CA2—osteoporosis	4.31e-05	0.00132	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—OXCT1—osteoporosis	4.31e-05	0.00132	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—POMC—osteoporosis	4.27e-05	0.0013	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.22e-05	0.00129	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MGLL—osteoporosis	4.2e-05	0.00128	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PGLS—osteoporosis	4.11e-05	0.00125	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPD2—osteoporosis	4.11e-05	0.00125	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CA2—osteoporosis	3.96e-05	0.00121	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—OXCT1—osteoporosis	3.96e-05	0.00121	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CALCR—osteoporosis	3.91e-05	0.00119	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTH1R—osteoporosis	3.91e-05	0.00119	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MGLL—osteoporosis	3.86e-05	0.00118	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PTH—osteoporosis	3.82e-05	0.00117	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ATIC—osteoporosis	3.76e-05	0.00115	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PNP—osteoporosis	3.76e-05	0.00115	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	3.75e-05	0.00114	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CNR2—osteoporosis	3.73e-05	0.00114	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.59e-05	0.0011	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—IDH2—osteoporosis	3.58e-05	0.00109	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTH—osteoporosis	3.47e-05	0.00106	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—POMC—osteoporosis	3.47e-05	0.00106	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.39e-05	0.00104	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CNR2—osteoporosis	3.38e-05	0.00103	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP27A1—osteoporosis	3.36e-05	0.00103	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—IDH2—osteoporosis	3.28e-05	0.001	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PKM—osteoporosis	3.28e-05	0.001	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—FDPS—osteoporosis	3.28e-05	0.001	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ACP5—osteoporosis	3.27e-05	0.000998	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—OXCT1—osteoporosis	3.2e-05	0.000976	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA2—osteoporosis	3.2e-05	0.000976	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—WNT1—osteoporosis	3.18e-05	0.000972	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PTHLH—osteoporosis	3.17e-05	0.000968	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6—osteoporosis	3.13e-05	0.000954	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MGLL—osteoporosis	3.11e-05	0.000951	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PGLS—osteoporosis	3.11e-05	0.000948	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPD2—osteoporosis	3.11e-05	0.000948	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MGLL—osteoporosis	3.1e-05	0.000947	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP27A1—osteoporosis	3.09e-05	0.000942	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.08e-05	0.00094	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6—osteoporosis	3.05e-05	0.00093	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TPI1—osteoporosis	3.04e-05	0.000928	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LRP5—osteoporosis	3.03e-05	0.000925	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ACP5—osteoporosis	3e-05	0.000916	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TGFB1—osteoporosis	2.96e-05	0.000904	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LRP6—osteoporosis	2.9e-05	0.000884	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TGFB1—osteoporosis	2.89e-05	0.000881	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTHLH—osteoporosis	2.88e-05	0.000879	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—P4HB—osteoporosis	2.86e-05	0.000873	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PNP—osteoporosis	2.84e-05	0.000867	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ATIC—osteoporosis	2.84e-05	0.000867	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GAPDH—osteoporosis	2.81e-05	0.000856	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TPI1—osteoporosis	2.79e-05	0.000852	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CALCA—osteoporosis	2.79e-05	0.000852	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—osteoporosis	2.76e-05	0.000844	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—RAP1A—osteoporosis	2.73e-05	0.000834	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—osteoporosis	2.69e-05	0.000822	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—IDH2—osteoporosis	2.65e-05	0.000808	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—P4HB—osteoporosis	2.62e-05	0.000801	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—POMC—osteoporosis	2.58e-05	0.000789	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GAPDH—osteoporosis	2.58e-05	0.000786	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CALCA—osteoporosis	2.53e-05	0.000774	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—RAP1A—osteoporosis	2.51e-05	0.000766	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP27A1—osteoporosis	2.49e-05	0.00076	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TLN1—osteoporosis	2.45e-05	0.000747	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ACP5—osteoporosis	2.42e-05	0.000739	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—OXCT1—osteoporosis	2.42e-05	0.000737	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA2—osteoporosis	2.42e-05	0.000737	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MGLL—osteoporosis	2.35e-05	0.000718	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TPI1—osteoporosis	2.25e-05	0.000687	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—osteoporosis	2.23e-05	0.000681	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.22e-05	0.000677	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ENO1—osteoporosis	2.21e-05	0.000674	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PSMA2—osteoporosis	2.18e-05	0.000664	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PSMA5—osteoporosis	2.18e-05	0.000664	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—osteoporosis	2.17e-05	0.000664	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—P4HB—osteoporosis	2.12e-05	0.000646	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—P4HB—osteoporosis	2.11e-05	0.000644	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—osteoporosis	2.1e-05	0.000641	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GAPDH—osteoporosis	2.08e-05	0.000634	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTH—osteoporosis	2.05e-05	0.000626	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO1—osteoporosis	2.03e-05	0.000619	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—RAP1A—osteoporosis	2.02e-05	0.000618	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAP1A—osteoporosis	2.02e-05	0.000616	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—IDH2—osteoporosis	2e-05	0.000611	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CNR2—osteoporosis	2e-05	0.00061	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PSMA2—osteoporosis	2e-05	0.00061	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PSMA5—osteoporosis	2e-05	0.00061	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	1.98e-05	0.000606	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NFATC1—osteoporosis	1.97e-05	0.000601	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DKK1—osteoporosis	1.95e-05	0.000596	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.88e-05	0.000574	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—WNT1—osteoporosis	1.88e-05	0.000574	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ACP5—osteoporosis	1.83e-05	0.000559	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGA—osteoporosis	1.83e-05	0.000558	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.81e-05	0.000552	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ADCY5—osteoporosis	1.8e-05	0.00055	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP19A1—osteoporosis	1.77e-05	0.000539	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TPI1—osteoporosis	1.7e-05	0.000519	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BMP2—osteoporosis	1.7e-05	0.000519	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTHLH—osteoporosis	1.7e-05	0.000519	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGB—osteoporosis	1.66e-05	0.000508	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO1—osteoporosis	1.64e-05	0.000499	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.62e-05	0.000495	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSMA2—osteoporosis	1.61e-05	0.000492	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSMA5—osteoporosis	1.61e-05	0.000492	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSMA5—osteoporosis	1.61e-05	0.00049	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSMA2—osteoporosis	1.61e-05	0.00049	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—P4HB—osteoporosis	1.6e-05	0.000488	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.57e-05	0.000479	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.53e-05	0.000467	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CALCA—osteoporosis	1.5e-05	0.000457	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—POMC—osteoporosis	1.46e-05	0.000446	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ADCY5—osteoporosis	1.44e-05	0.00044	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX1—osteoporosis	1.44e-05	0.000439	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KL—osteoporosis	1.36e-05	0.000415	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.33e-05	0.000407	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—osteoporosis	1.33e-05	0.000405	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—POMC—osteoporosis	1.33e-05	0.000405	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ADCY5—osteoporosis	1.32e-05	0.000404	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX1—osteoporosis	1.32e-05	0.000403	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.31e-05	0.000399	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.29e-05	0.000395	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO1—osteoporosis	1.24e-05	0.000377	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.22e-05	0.000372	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.22e-05	0.000372	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—osteoporosis	1.22e-05	0.000372	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADCY5—osteoporosis	1.07e-05	0.000326	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX1—osteoporosis	1.06e-05	0.000325	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.06e-05	0.000325	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POMC—osteoporosis	1.06e-05	0.000324	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.03e-05	0.000314	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.88e-06	0.000302	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—osteoporosis	9.83e-06	0.0003	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POMC—osteoporosis	9.74e-06	0.000297	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IRS2—osteoporosis	9.32e-06	0.000284	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LEP—osteoporosis	9.12e-06	0.000278	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ESR1—osteoporosis	8.7e-06	0.000266	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IRS1—osteoporosis	8.13e-06	0.000248	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADCY5—osteoporosis	8.08e-06	0.000247	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX1—osteoporosis	8.05e-06	0.000246	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POMC—osteoporosis	7.86e-06	0.00024	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—POMC—osteoporosis	7.83e-06	0.000239	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6R—osteoporosis	7.64e-06	0.000233	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—osteoporosis	7.53e-06	0.00023	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—osteoporosis	7.43e-06	0.000227	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POMC—osteoporosis	5.94e-06	0.000181	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—osteoporosis	5.76e-06	0.000176	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—osteoporosis	4.53e-06	0.000138	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.52e-06	0.000138	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—osteoporosis	3.4e-06	0.000104	CbGpPWpGaD
